High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats (Q40067011)

17 September 2017

title

High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats (English)

1 reference

17 September 2017

1 reference

Satoshi Hagiwara

1

1 reference

17 September 2017

Hideo Iwasaka

series ordinal

2

1 reference

17 September 2017

Shigekiyo Matsumoto

series ordinal

3

1 reference

17 September 2017

Takayuki Noguchi

series ordinal

4

1 reference

17 September 2017

publication date

17 October 2007

1 reference

17 September 2017

published in

Intensive Care Medicine

1 reference

17 September 2017

volume

34

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

361-367

1 reference

Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins

17 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00134-007-0887-5

Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00134-007-0887-5

Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00134-007-0887-5

The efficacy of heparin and antithrombin III in fluid-resuscitated cecal ligation and puncture.

21 January 2018

1 reference

12 December 2020

The role of the endothelium in changes in procoagulant activity in sepsis

1 reference

12 December 2020

Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

1 reference

12 December 2020

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

1 reference

12 December 2020

Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis

1 reference

12 December 2020

Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells

1 reference

12 December 2020

The role of high mobility group box-1 protein in severe sepsis

1 reference

12 December 2020

Year in review in intensive care medicine, 2005. II. Infection and sepsis, ventilator-associated pneumonia, ethics, haematology and haemostasis, ICU organisation and scoring, brain injury

1 reference

12 December 2020

Severe sepsis--a new treatment with both anticoagulant and antiinflammatory properties

1 reference

12 December 2020

Transcription factors as activators of gene transcription: AP-1 and NF-kappa B.

1 reference

12 December 2020

Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding

1 reference

12 December 2020

Year in review in intensive care medicine, 2004. I. Respiratory failure, infection, and sepsis

1 reference

12 December 2020

Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep.

1 reference

12 December 2020

High mobility group box 1 protein interacts with multiple Toll-like receptors

1 reference

12 December 2020

Effects of antithrombin III on tumor necrosis factor-alpha and interleukin-1beta synthesis in vascular smooth muscle cells

1 reference

12 December 2020

Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin

1 reference

12 December 2020

Contributions of high mobility group box protein in experimental and clinical acute lung injury.

1 reference

12 December 2020

Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock*

1 reference

12 December 2020

High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety

1 reference

12 December 2020

A meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis

1 reference

12 December 2020

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

12 December 2020

Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation

1 reference

12 December 2020

HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.

1 reference

12 December 2020

Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation

1 reference

12 December 2020

Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III

1 reference

12 December 2020

Antithrombin III and sepsis

1 reference

12 December 2020

HMG-1 rediscovered as a cytokine

1 reference

12 December 2020

What can we learn from the three megatrials using anticoagulants in severe sepsis?

1 reference

12 December 2020

10.1007/S00134-007-0887-5

Identifiers

DOI

1 reference

17 September 2017

1 reference